The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
Authors
Keywords
-
Journal
Biomedicines
Volume 9, Issue 4, Pages 433
Publisher
MDPI AG
Online
2021-04-16
DOI
10.3390/biomedicines9040433
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PFRED: A computational platform for siRNA and antisense oligonucleotides design
- (2021) Simone Sciabola et al. PLoS One
- Antisense technology: an overview and prospectus
- (2021) Stanley T. Crooke et al. NATURE REVIEWS DRUG DISCOVERY
- Golodirsen: First Approval
- (2020) Young-A Heo DRUGS
- Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
- (2020) Diane E. Frank et al. NEUROLOGY
- The Importance of Poly(ethylene glycol) Alternatives for Overcoming PEG Immunogenicity in Drug Delivery and Bioconjugation
- (2020) Thai Thanh Hoang Thi et al. Polymers
- DNA Nanostructure as an Efficient Drug Delivery Platform for Immunotherapy
- (2020) Qingjia Chi et al. Frontiers in Pharmacology
- RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
- (2020) Sarah Bajan et al. Cells
- MTL-CEBPA, a small activating RNA therapeutic up-regulating C/EBP-α, in patients with advanced liver cancer: a first-in-human, multi-centre, open-label, phase I trial
- (2020) Debashis Sarker et al. CLINICAL CANCER RESEARCH
- Phosphorothioate modified oligonucleotide–protein interactions
- (2020) Stanley T Crooke et al. NUCLEIC ACIDS RESEARCH
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
- (2020) Paula R. Clemens et al. JAMA Neurology
- Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications
- (2020) Shuaijian Ni et al. ACS Applied Materials & Interfaces
- Viltolarsen: First Approval
- (2020) Sohita Dhillon DRUGS
- Advances in oligonucleotide drug delivery
- (2020) Thomas C. Roberts et al. NATURE REVIEWS DRUG DISCOVERY
- Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
- (2020) Timothy Miller et al. NEW ENGLAND JOURNAL OF MEDICINE
- NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation
- (2020) Tina R. Lewis et al. PLoS One
- Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer
- (2020) Olivia D. Lara et al. Oncotarget
- Antisense oligonucleotide- and CRISPR-Cas9-mediated rescue of mRNA splicing for a deep intronic CLRN1 mutation
- (2020) Anna-Lena Panagiotopoulos et al. Molecular Therapy-Nucleic Acids
- Barriers and strategies of cationic liposomes for cancer gene therapy
- (2020) Chunyan Liu et al. Molecular Therapy-Methods & Clinical Development
- Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study
- (2020) Dorte S. Nørøxe et al. Molecular Oncology
- Modified Nucleic Acids: Expanding the Capabilities of Functional Oligonucleotides
- (2020) Steven Ochoa et al. MOLECULES
- Some ASOs that bind in the coding region of mRNAs and induce RNase H1 cleavage can cause increases in the pre-mRNAs that may blunt total activity
- (2020) Xue-hai Liang et al. NUCLEIC ACIDS RESEARCH
- KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma
- (2020) Xiuzhi Zhang et al. Frontiers in Genetics
- Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study
- (2020) Beate Schultheis et al. Cancers
- Therapeutic advances of miRNAs: A preclinical and clinical update
- (2020) Chiranjib Chakraborty et al. Journal of Advanced Research
- Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
- (2020) Muhammad Imran Sajid et al. Pharmaceuticals
- Viltolarsen in Japanese Duchenne muscular dystrophy patients: A phase 1/2 study
- (2020) Hirofumi Komaki et al. Annals of Clinical and Translational Neurology
- Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer
- (2020) Guillaume Sicard et al. Pharmaceutics
- Multifunctional Delivery Systems for Peptide Nucleic Acids
- (2020) Stefano Volpi et al. Pharmaceuticals
- Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2019) Federica Fogacci et al. DRUGS
- Differential uptake, kinetics and mechanisms of intracellular trafficking of next-generation antisense oligonucleotides across human cancer cell lines
- (2019) Emily Linnane et al. NUCLEIC ACIDS RESEARCH
- Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis
- (2019) Veena Mathew et al. Drug Design Development and Therapy
- The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer
- (2019) Kazuki Takakura et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice
- (2019) Arnaud F. Klein et al. JOURNAL OF CLINICAL INVESTIGATION
- Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
- (2019) Jinkuk Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?
- (2019) Oliver S. Thomas et al. Frontiers in Bioengineering and Biotechnology
- Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models
- (2018) Alex McCampbell et al. JOURNAL OF CLINICAL INVESTIGATION
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- (2018) Eugenio Mercuri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute hepatotoxicity of 2′ fluoro-modified 5–10–5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins
- (2018) Wen Shen et al. NUCLEIC ACIDS RESEARCH
- The Role of Grb2 in Cancer and Peptides as Grb2 Antagonists
- (2018) Muhammad Ijaz et al. PROTEIN AND PEPTIDE LETTERS
- Endosomal Escape of Antisense Oligonucleotides Internalized by Stabilin Receptors Is Regulated by Rab5C and EEA1 During Endosomal Maturation
- (2018) Colton M. Miller et al. Nucleic Acid Therapeutics
- Antibody-Antisense Oligonucleotide Conjugate Downregulates a Key Gene in Glioblastoma Stem Cells
- (2018) Amy E. Arnold et al. Molecular Therapy-Nucleic Acids
- Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial
- (2018) Maro Ohanian et al. Lancet Haematology
- Exosome-like nanovectors for drug delivery in cancer
- (2018) Noemi Arrighetti et al. CURRENT MEDICINAL CHEMISTRY
- Inotersen: First Global Approval
- (2018) Susan J. Keam DRUGS
- Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system
- (2017) Bai Xiang et al. International Journal of Nanomedicine
- Recent Trends in Clinical Trials Related to Carrier-Based Drugs
- (2017) Tatsuaki Tagami et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus
- (2017) Xue-Hai Liang et al. MOLECULAR THERAPY
- The chemical evolution of oligonucleotide therapies of clinical utility
- (2017) Anastasia Khvorova et al. NATURE BIOTECHNOLOGY
- Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs
- (2017) Xiulong Shen et al. NUCLEIC ACIDS RESEARCH
- Stimuli-responsive liposomes for drug delivery
- (2017) Y. Lee et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Eteplirsen in the treatment of Duchenne muscular dystrophy
- (2017) Kenji Rowel Lim et al. Drug Design Development and Therapy
- Fluorinated Nucleotide Modifications Modulate Allele Selectivity of SNP-Targeting Antisense Oligonucleotides
- (2017) Michael E. Østergaard et al. Molecular Therapy-Nucleic Acids
- Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape
- (2016) Claudia Zylberberg et al. DRUG DELIVERY
- Eteplirsen: First Global Approval
- (2016) Yahiya Y. Syed DRUGS
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
- (2016) Nicholas J Viney et al. LANCET
- Novel Targeted Therapy for Precursor B-Cell Acute Lymphoblastic Leukemia: Anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate
- (2016) Noriko Satake et al. MOLECULAR MEDICINE
- Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames
- (2016) Xue-hai Liang et al. NATURE BIOTECHNOLOGY
- Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers
- (2016) Susanne Schöttler et al. Nature Nanotechnology
- RNA cleavage products generated by antisense oligonucleotides and siRNAs are processed by the RNA surveillance machinery
- (2016) Walt F. Lima et al. NUCLEIC ACIDS RESEARCH
- The delivery of therapeutic oligonucleotides
- (2016) Rudolph L. Juliano NUCLEIC ACIDS RESEARCH
- Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide Drugs
- (2016) Sabine Sewing et al. PLoS One
- Modulation of Bcl-x Alternative Splicing Induces Apoptosis of Human Hepatic Stellate Cells
- (2016) Lin Wu et al. Biomed Research International
- Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging
- (2016) Linda S. Steelman et al. Aging-US
- Clinical and Preclinical Pharmacokinetics and Pharmacodynamics of Mipomersen (Kynamro®): A Second-Generation Antisense Oligonucleotide Inhibitor of Apolipoprotein B
- (2015) Richard S. Geary et al. CLINICAL PHARMACOKINETICS
- Oligonucleotide Therapies: The Past and the Present
- (2015) Karin E. Lundin et al. HUMAN GENE THERAPY
- Liposomes as nanomedical devices
- (2015) Giuseppina Bozzuto et al. International Journal of Nanomedicine
- Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages
- (2015) Xue-hai Liang et al. NUCLEIC ACIDS RESEARCH
- The rates of the major steps in the molecular mechanism of RNase H1-dependent antisense oligonucleotide induced degradation of RNA
- (2015) Timothy A. Vickers et al. NUCLEIC ACIDS RESEARCH
- 2′-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF
- (2015) Wen Shen et al. NUCLEIC ACIDS RESEARCH
- Data mining The Cancer Genome Atlas in the era of precision cancer medicine
- (2015) PF Cheng et al. SWISS MEDICAL WEEKLY
- Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
- (2015) Katarzyna Tomczak et al. Wspolczesna Onkologia-Contemporary Oncology
- DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing
- (2015) Kazutaka Nishina et al. Nature Communications
- Influence of cholesterol on liposome stability and on in vitro drug release
- (2015) Maria-Lucia Briuglia et al. Drug Delivery and Translational Research
- A review on phospholipids and their main applications in drug delivery systems
- (2015) Jing Li et al. Asian Journal of Pharmaceutical Sciences
- Cell-Penetrating Peptides: Design, Synthesis, and Applications
- (2014) Dana Maria Copolovici et al. ACS Nano
- A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery
- (2014) Shivani Rai Paliwal et al. DRUG DELIVERY
- Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01
- (2014) Ana Tari Ashizawa et al. Expert Opinion on Drug Delivery
- Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt)
- (2014) Jacquelyn L. Sikora et al. HUMAN GENETICS
- Targeted delivery of antisense oligonucleotides to hepatocytes using triantennaryN-acetyl galactosamine improves potency 10-fold in mice
- (2014) Thazha P. Prakash et al. NUCLEIC ACIDS RESEARCH
- Cholesterol level affects surface charge of lipid membranes in saline solution
- (2014) Aniket Magarkar et al. Scientific Reports
- Application of liposomes in medicine and drug delivery
- (2014) Hadis Daraee et al. Artificial Cells Nanomedicine and Biotechnology
- Imperfect centered miRNA binding sites are common and can mediate repression of target mRNAs
- (2014) Hilary C Martin et al. GENOME BIOLOGY
- XRN 5′→3′ exoribonucleases: Structure, mechanisms and functions
- (2013) Vinay K. Nagarajan et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer
- (2013) D Bianchini et al. BRITISH JOURNAL OF CANCER
- A perspective on mammalian upstream open reading frame function
- (2013) Joanna Somers et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
- (2013) Amr S. Abu Lila et al. JOURNAL OF CONTROLLED RELEASE
- Rational design of antisense oligonucleotides targeting single nucleotide polymorphisms for potent and allele selective suppression of mutant Huntingtin in the CNS
- (2013) Michael E. Østergaard et al. NUCLEIC ACIDS RESEARCH
- Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP)
- (2013) A Seda Yılmaz-Eliş et al. Molecular Therapy-Nucleic Acids
- Surface Engineering of Liposomes for Stealth Behavior
- (2013) Okhil Nag et al. Pharmaceutics
- Single-Stranded RNAs Use RNAi to Potently and Allele-Selectively Inhibit Mutant Huntingtin Expression
- (2012) Dongbo Yu et al. CELL
- Structure and nuclease resistance of 2′,4′-constrained 2′-O-methoxyethyl (cMOE) and 2′-O-ethyl (cEt) modified DNAs
- (2012) Pradeep S. Pallan et al. CHEMICAL COMMUNICATIONS
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment
- (2012) Corinne Betts et al. Molecular Therapy-Nucleic Acids
- Zwitteration As an Alternative to PEGylation
- (2011) Zaki G. Estephan et al. LANGMUIR
- A feedback loop regulates splicing of the spinal muscular atrophy-modifying gene, SMN2
- (2010) Francine M. Jodelka et al. HUMAN MOLECULAR GENETICS
- Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
- (2010) Frederick J Raal et al. LANCET
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now